Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Sulindac and Tamoxifen in Patients With Desmoid Tumors That Are Recurrent or Not Amenable to Standard Therapy

NCT00068419 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00068419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00068419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Sulindac and Tamoxifen in Patients With Desmoid Tumors That Are Recurrent or Not Amenable to Standard Therapy
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2004
Completion date
April 26, 2010
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

desmoid tumor